Neil A Robertson
Overview
Explore the profile of Neil A Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gadd D, Hillary R, McCartney D, Shi L, Stolicyn A, Robertson N, et al.
Nat Commun
. 2022 Aug;
13(1):4670.
PMID: 35945220
Characterising associations between the methylome, proteome and phenome may provide insight into biological pathways governing brain health. Here, we report an integrated DNA methylation and phenotypic study of the circulating...
2.
Robertson N, Latorre-Crespo E, Terradas-Terradas M, Lemos-Portela J, Purcell A, Livesey B, et al.
Nat Med
. 2022 Jul;
28(7):1439-1446.
PMID: 35788175
Clonal hematopoiesis of indeterminate potential (CHIP) increases rapidly in prevalence beyond age 60 and has been associated with increased risk for malignancy, heart disease and ischemic stroke. CHIP is driven...
3.
Cole J, Faydaci B, McGuinness D, Shaw R, Maciewicz R, Robertson N, et al.
BMC Bioinformatics
. 2021 Aug;
22(1):411.
PMID: 34412594
Background: Once bulk RNA-seq data has been processed, i.e. aligned and then expression and differential tables generated, there remains the essential process where the biology is explored, visualized and interpreted....
4.
Latif A, Newcombe A, Li S, Gilroy K, Robertson N, Lei X, et al.
Nat Commun
. 2021 Jan;
12(1):241.
PMID: 33431824
Acute myeloid leukemia (AML) is a typically lethal molecularly heterogeneous disease, with few broad-spectrum therapeutic targets. Unusually, most AML retain wild-type TP53, encoding the pro-apoptotic tumor suppressor p53. MDM2 inhibitors...
5.
Terradas-Terradas M, Robertson N, Chandra T, Kirschner K
Mech Ageing Dev
. 2020 Jun;
189:111279.
PMID: 32526214
Clonal haematopoiesis of indeterminate potential (CHIP) is widespread in the elderly. CHIP is driven by somatic mutations in leukaemia driver genes, such as Janus Kinase 2 (JAK2), Tet methylcytosine dioxygenase...
6.
Guzniczak E, Otto O, Whyte G, Chandra T, Robertson N, Willoughby N, et al.
Biotechnol Bioeng
. 2020 Feb;
117(7):2032-2045.
PMID: 32100873
Cell-based therapeutics, such as in vitro manufactured red blood cells (mRBCs), are different to traditional biopharmaceutical products (the final product being the cells themselves as opposed to biological molecules such...
7.
MacKenzie D, Robertson N, Rather I, Reid C, Sendzikaite G, Cruickshanks H, et al.
iScience
. 2020 Feb;
23(2):100838.
PMID: 32058953
Approximately 10% of human colorectal cancer (CRC) are associated with activated BRAFV600E mutation, typically in absence of APC mutation and often associated with a CpG island methylator (CIMP) phenotype. To...
8.
Vizioli M, Liu T, Miller K, Robertson N, Gilroy K, Lagnado A, et al.
Genes Dev
. 2020 Feb;
34(5-6):428-445.
PMID: 32001510
Cellular senescence is a potent tumor suppressor mechanism but also contributes to aging and aging-related diseases. Senescence is characterized by a stable cell cycle arrest and a complex proinflammatory secretome,...
9.
Robertson N, Hillary R, McCartney D, Terradas-Terradas M, Higham J, Sproul D, et al.
Curr Biol
. 2019 Aug;
29(16):R786-R787.
PMID: 31430471
Age-related clonal haemopoiesis (ARCH) in healthy individuals was initially observed through an increased skewing in X-chromosome inactivation [1]. More recently, several groups reported that ARCH is driven by somatic mutations...
10.
Field A, Robertson N, Wang T, Havas A, Ideker T, Adams P
Mol Cell
. 2018 Sep;
71(6):882-895.
PMID: 30241605
Age-associated changes to the mammalian DNA methylome are well documented and thought to promote diseases of aging, such as cancer. Recent studies have identified collections of individual methylation sites whose...